Publications by authors named "B el Said"

Shock is a state of inadequate perfusion that affects vital organs. Cardiogenic shock (CS) predisposes patients to various arrhythmias. The adverse effect depends on intervention and pharmacogenomics.

View Article and Find Full Text PDF

This research paper presents a detailed investigation into the morphometric characteristics of sub-basins within the Naama region of Algeria, aiming to prioritize areas vulnerable to soil erosion and runoff risks. Focusing on five key sub-basins that collectively represent 75% of the Wilaya of Naama, the study employs a comprehensive methodological framework, integrating morphometric analysis (MA), weighted sum analysis (WSA), principal component analysis (PCA), and the novel approach of compositional data analysis (CoDA). Through the rigorous evaluation of sixteen distinct morphometric parameters selected based on their relevance to hydrological and geomorphological processes that influence erosion and runoff, this research provides a nuanced understanding of the factors influencing erosion susceptibility within each sub-basin.

View Article and Find Full Text PDF

This study presents a new method for simultaneously quantifying a complex anti-migraine formulation containing five components (ergotamine, propyphenazone, caffeine, camylofin, and mecloxamine) using UV spectrophotometry and chemometric models. The formulation presents analytical challenges due to the wide variation in component concentrations (ERG: PRO: CAF: CAM: MEC ratio of 0.075:20:8:5:4) and highly overlapping UV spectra.

View Article and Find Full Text PDF

The unique medical and socio-economic situation in each country affected by TB creates different epidemiological contexts, thus providing exploitable loopholes for the spread of the disease. Country-specific factors such as comorbidities, health insurance, social stigma or the rigidity of the health system complicate the management of TB and the overall outcome of each patient. First-line TB drugs are administered in a standardized manner, regardless of patient characteristics other than weight.

View Article and Find Full Text PDF

Background: The end tuberculosis (TB) strategy requires a novel patient treatment approach contrary to the one-size-fits-all model. It is well known that each patient's physiology is different and leads to various rates of drug elimination. Therapeutic drug monitoring (TDM) offers a way to manage drug dosage adaptation but requires trained pharmacologists, which is scarce in resource-limited settings.

View Article and Find Full Text PDF